We give general arguments that show that the linear magnetoelectric effect in antiferromagnetic materials gives rise to a magnetocapacitance anomaly—a divergence of the dielectric constant at the magnetic ordering temperature $T_N$ that appears in an applied magnetic field. The measurement of magnetodielectric response thus provides a definitive and experimentally accessible method to recognize antiferromagnetic linear magnetoelectric materials, circumventing the experimental difficulties often involved in measuring electric polarization. We confirm this result experimentally using the example of MnTiO${}_3$, which we show to exhibit the linear magnetoelectric effect. No dielectric anomaly is observed at $T_N$ in the absence of an applied magnetic field. However, a sharp peak in the dielectric constant appears here when a magnetic field is applied along the $c$ axis, reflecting a linear coupling of the polarization $P$ with the antiferromagnetic order parameter $L$. In accordance with our theoretical analysis, the dielectric constant close to $T_N$ increases with the square of the magnetic field.

We have studied the magnetodieletric coupling of polycrystalline samples of the spinels MCr(2)O(4) (M = Mn, Co and Ni). Dielectric anomalies are clearly observed at the onset of the magnetic spiral structure (T(s)) and at the 'lock-in' transition (T(f)) in MnCr(2)O(4) and CoCr(2)O(4), and also at the onset of the canted structure (T(s)) in NiCr(2)O(4). The strength of the magnetodielectric coupling in this system can be explained by spin-orbit coupling. Moreover, the dielectric response in an applied magnetic field scales with the square of the magnetization for all three samples. Thus, the magnetodielectric coupling in this state appears to originate from the P(2)M(2) term in the free energy.

In this study, we report the synthesis of the magnetite/silica nanocomposites and their structural and functional groups, magnetic properties, morphology, antimicrobial activity, and drug delivery performance. The X-ray diffraction characterization showed that magnetite formed a spinel phase and that silica formed an amorphous phase. The particle sizes of magnetite increased from 8.2 to 13.2 nm with increasing silica content, and the particles were observed to be superparamagnetic. The nanocomposites tended to agglomerate based on the scanning electron microscopy images. The antimicrobial activity of the magnetite/silica nanocomposites revealed that the increasing silica content increased the inhibition zones by 74%, 77%, and 143% in case of Gram-positive bacteria (B. subtilis), Gram-negative bacteria (E. coli), and fungus (C. albicans), respectively. Furthermore, doxorubicin was used as the model compound in the drug loading and release study, and drug loading was directly proportional to the silica content. Thus, the increasing silica content increased the drug loading owing to the increasing number of OH- bonds in silica, resulting in strong bonds with doxorubicin. Based on this study, the magnetite/silica nanocomposites could be applied as drug delivery vehicles.

The consumption of electrical energy grows alongside the development of global industry. Generating energy storage has become the primary focus of current research, examining supercapacitors with high power density. The primary raw material used in supercapacitor electrodes is activated carbon (AC). To improve the performance of activated carbon, we used manganese dioxide (MnO₂), which has a theoretical capacitance of up to 1370 Fg⁻¹. The composite-based activated carbon with a different mass of 0–20% MnO₂ was successfully introduced as the positive electrode. The asymmetric cell supercapacitors based on activated carbon as the anode delivered an excellent gravimetric capacitance, energy density, and power density of 84.28 Fg⁻¹, 14.88 Wh.kg⁻¹, and 96.68 W.kg⁻¹, respectively, at 1 M Et₄NBF₄, maintaining 88.88% after 1000 test cycles.